期刊文献+

血清学指标对噬血细胞综合征患儿死亡预测价值的临床研究 被引量:7

Clinical study on the early prediction of death for serum markers in infants with hemophagocytic syndrome
原文传递
导出
摘要 目的 探讨噬血细胞综合征(hemophagocytic syndrome,HPS)患儿诊断时的血清学指标与死亡的关系及对死亡的早期预测价值.方法 采用回顾性病例对照研究方法,对2005年7月至2012年7月广州市妇女儿童医疗中心收治的108例HPS患儿血清学、病理学改变及预后资料进行系统分析.按随访患儿的生存情况分为存活组和死亡组,应用COX模型对可能与HPS死亡相关的危险因素进行分析;应用决策树探讨各指标对HPS死亡的预测价值.结果 108例HPS患儿中,死亡33例,病死率30.6%,且90.3%在发病后8周内死亡.多因素分析显示白细胞<5×109/L(HR =9.08,95% CI3.07 ~26.87)、血红蛋白<80 g/L(HR =6.15,95% CI 1.68 ~ 22.49)、白蛋白<28g/L(HR=4.63,95%CI 1.12 ~7.39)、铁蛋白>1 100 μg/L(HR =3.05,95% CI 1.28 ~ 16.75)、甘油三酯≥4 mmol/L(HR=2.88,95%CI 1.51 ~8.60)、凝血酶原时间≥16s(HR=3.60,95%CI 1.28 ~7.24)和发热持续2周以上(HR =5.39,95%CI 1.97~14.66)是造成HPS患儿死亡的独立危险因子.决策树分析显示白细胞<5×109/L合并血红蛋白<80 g/L的情况下患儿死亡概率达100%;即使在白细胞≥5×109/L的情况下,若合并发热持续2周以上且总胆固醇≥4 mmol/L,死亡概率亦达66.7%.结论 发病后最初8周是治疗HPS的关键期,HPS患儿死亡与多种因素相关,合并白细胞<5×109/L且血红蛋白<80 g/L时,病情极其凶险,及早诊断并采取有针对性的治疗对降低HPS患儿病死率至关重要. Objective To investigate the association with death for serum parameters at the time of diagnosis and its value in predicting the death in infants with hemophagocytic syndrome (HPS).Methods A retrospective case-control study was conducted on 108 children with HPS who were admitted to our center between July 2005 and July 2012.For each patient,demographic,laboratory data and outcome information were collected.The patients were divided into death and surviving groups based on the follow-up results.The relation between serum markers and death was examined using the COX proportional hazards model and decision tree.Results Of 108 infants with HPS,33 died corresponding to a fatality rate of 30.6% and 90.3% of deaths occurred within 8 weeks after diagnosis.Following features were significantly associated with death:white blood cells (WBC) 〈5 x 109/L (HR =9.08,95% CI 3.07 ~ 26.87),hemoglobin 〈80 g/L (HR =6.15,95% CI 1.68 ~ 22.49),albumin 〈 28 g/L (HR =4.63,95% CI 1.12 ~ 7.39),serum ferritin 〉 1 100 μg/L (HR =3.05,95% CI 1.28 ~ 16.75),trigeminal ganglion ≥4 mmol/L (HR =2.88,95% CI 1.51 ~ 8.60),and prothromin time ≥ 16 s (HR =3.60,95 % CI 1.28 ~ 7.24),and fever for more than 2 weeks (HR =5.39,95% CI 1.97 ~ 14.66).Decision tree demonstrated that the probability of death was as high as 100% for infants with WBC 〈5 x 109/L and hemoglobin 〈 80 g/L.The odds of dying was still 66.7% for infants who had WBC≥5 × 109/L but reported trigeminal ganglion ≥4 mmol/L after having fever for more than 2 weeks.Conclusion The first 8 weeks after the onset of HPS is the critical period of treatment.There are several easily available serum predictors of early mortality in HPS infants,particularly the WBC and hemoglobin level,which may help guide treatment decisions.
出处 《中国小儿急救医学》 CAS 2013年第2期144-148,共5页 Chinese Pediatric Emergency Medicine
基金 广东省科技厅科研基金立项课题(83087)
关键词 噬血细胞综合征 死亡 危险因素 儿童 Hemophagocytic syndrome Death Risk factors Children
  • 相关文献

参考文献16

  • 1Janka GE. Hemophagocytic syndromes. Blood Rev, 2007,21 ( 5 ) :245-253.
  • 2Freeman HR, Ramanan AV. Review of haemophagocytic lym- phohistiocytosis. Arch Dis Child ,2011,96 ( 7 ) :688-693.
  • 3Janka GE. Familial and acquired hemophagocytic lymphohistio- cytosis. Eur J Pediatr ,2007,166 (2) ..95-109.
  • 4Weitzman S. Approach to hemophagocytic syndromes. Hematol- ogy Am Soc Hematol Educ Program,2011,2011 ( 1 ) :178-183.
  • 5Chan JS, Shing MM, Lee V, et al. Haemophagocytic lymphohis- tiocytosis in Hong Kong children. Hong Kong Med J,2008,14 (4) :308-313.
  • 6Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocyto- sis: diagnosis, pathophysiology, treatment, and future perspec- tives. Ann Meal,2006,38( 1 ) :20-31.
  • 7Trottestam H, Berglof E, Home A, et al. Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta Paediatr,2012,101 (3) :313-318.
  • 8Henter Jl, Home A, A_rico M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer,2007,48 ( 2 ) : 124-131.
  • 9王冠玲,胡群,张柳清,刘爱国,刘双又,张耀东,孙燕,熊昊.儿童噬血细胞综合征死亡相关因素分析[J].临床儿科杂志,2010,28(5):438-441. 被引量:13
  • 10Tanoshima R, Takahashi H, Hokosaki T, et al. Hemophagocytic lymphohistiocytosis in very young infants. Pediatr Blood Canc- er,2009,52( 1 ) : 137-139.

二级参考文献32

  • 1金颖康,谢正德,杜忠东,杨双,申昆玲.儿童Epstein-Barr病毒相关性噬血细胞性淋巴组织细胞增生症的回顾性分析[J].首都医科大学学报,2010(2):192-196. 被引量:11
  • 2郭霞,李强,周晨燕.儿童噬血细胞综合征41例临床分析[J].中华血液学杂志,2007,28(7):449-453. 被引量:26
  • 3Henter JI,Horne A,Arico M,et al.HLH-2004:diagno-sis and therapeutic guidelines for hemophagocytic lympho-histiocytosis[J].Pediatr Blood Cancer,2007,48(2):124-131.
  • 4Janka G.Familial and acquired hemophagocytic lympho-histiocytosis[J].Eur J Pediatr,2007,166(2):95-109.
  • 5Imashuku S,Hyakuna N,Funabiki T,et al.Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with hemophagocytic lymphohistocytosis[J].Cancer,2002,94(11):3023-3031.
  • 6Imashuku S,Teramura T,Tauchi H,et al.Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis[J].Haematologica,2004,89(2):183-188.
  • 7杨骏,张永红,谢正德,杨双,吴润晖.儿童EB病毒相关噬血淋巴组织细胞增生症26例[J].中国小儿血液与肿瘤杂志,2007,12(4):157-160. 被引量:7
  • 8Gholam C, Grigoriadou S, Gilmour KC, et al.Familial haemo- phagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management [J].Clin Exp Immunol, 2011, 163 (3) :271-283.
  • 9Gurgey A, Gogus S, Ozyurek E, et al.Primary hemophagocytic lymphohistiocytosis in Turkish children[J].Pediatr Hematol On- col, 2003,20: 367-371.
  • 10Coo HW, Weon YC.A spectrum of neuroradiological findings in children with haemophagocytic lymphohistiocytosis [J].Pediatr Radiol,2007,37 : 1110-1117.

共引文献15

同被引文献77

  • 1郭霞,李强,周晨燕.儿童噬血细胞综合征41例临床分析[J].中华血液学杂志,2007,28(7):449-453. 被引量:26
  • 2李欣,徐酉华.EB病毒相关性噬血细胞综合征的研究进展[J].国际儿科学杂志,2007,34(5):328-331. 被引量:8
  • 3Henter JI, Home A, Arico M, et al. HLH-2004 : Diagnostic and ther- apeutic guidelines for hemophagocytic lymphohistiocytosis [ J ]. Pediatr Blood Cancer, 2007,48 (2) : 124-131.
  • 4Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis[J]. Annu Rev Meal,2012,63(3):233-246.
  • 5Weitzman S. Approach to hemophagoeytic syndromes [ J ]. Hematology Am Sac Hematol Edue Pmgram,2011,20 ( 11 ) : 178-183.
  • 6Rouphael NG,Talati NJ,Vaughan C,et al. Infections associated with hae- mophagocytic syndrome[ J ]. lancet Infect Dis ,2007,7 (12) :814-822.
  • 7Ishii E,Ohga S,Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan[J]. Int J Hematol,2007,86( l ) :58-65.
  • 8Imashuku S,TeramuraT,Tauchi H, et al. Longitudinal follow-up of pa- tients with Epstein-Barr virus-associated hemophagocytic lymphohistio- cytosis [ J ]. Haematologica, 2004,89 ( 2 ) : 183-188.
  • 9Ahn JS, Rew SY, Shin MG, et al. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis[ J]. Am J Hemato1,2010,85 (9) :719-722.
  • 10Imashuku S. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis ( EBV -HLH) ; update 2010 [ J ]. J Pediatr Hematol Oncol,2011,33( 1 ) :35-39.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部